Guangdong Hybribio Biotech Co.,Ltd. announced at the EGM held on August 31, 2022 that the company approved Election of Qiao Youlin, Yang Chunxue and Chen Yingshi as independent directors.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.69 CNY | -1.39% | -7.18% | -39.08% |
05-21 | Hybribio Biotech Gets Patent for Spinal Muscular Atrophy Gene Kit | MT |
05-16 | Hybribio Biotech Unit Gets Nod to Market Deafness Gene Detection Kit in China | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.08% | 504M | |
-6.21% | 12.2B | |
-3.06% | 8.22B | |
+6.01% | 5.72B | |
+26.16% | 5.42B | |
-10.38% | 4.09B | |
-59.63% | 2.7B | |
+9.56% | 2.63B | |
-4.16% | 2.38B | |
+21.00% | 2.1B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Guangdong Hybribio Biotech Co.,Ltd. Announces Director Appointments